Bionik Laboratories Corp. BNKL

Company Overview

Bionik Laboratories Corp. (formerly traded under the ticker BNKL) was a medical technology company focused on robotic rehabilitation and assistive technologies for patients with neurological and mobility impairments. The company operated primarily within the healthcare technology, rehabilitation robotics, and physical therapy equipment industries. Its core business centered on robotic systems designed to support rehabilitation therapy for stroke survivors and patients with upper-extremity motor impairments. Public filings and company materials identified the company’s primary commercial platform as the InMotion robotic therapy system line, which originated from research conducted at the Massachusetts Institute of Technology (MIT).

The company’s revenue model was historically tied to the sale, leasing, servicing, and support of rehabilitation robotics systems to hospitals, rehabilitation centers, research institutions, and healthcare providers. Bionik positioned itself around clinically supported robotic-assisted therapy designed to improve rehabilitation outcomes and therapy efficiency. The company evolved through acquisitions and restructuring activities that consolidated rehabilitation robotics technologies under the Bionik brand. Public disclosures indicate that the company experienced recurring financial challenges and operational constraints, and publicly available information regarding current large-scale commercial operations is limited. Data inconclusive based on available public sources regarding the company’s present operating scale and active commercial status.